Biomarkers in head and neck squamous cell carcinoma: unraveling the path to precision immunotherapy.

Front Oncol · 2024 · PMC11493772 · PMID 39439946

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

Haddad et al., observed a strong association between TMB and objective response, as well as a positive trend between neoantigen load and clinical response to pembrolizumab in patients with recurrent/metastatic HNSCC ( 90 ).

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.